Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Veltuzumab [USAN:INN]
RN: 728917-18-8
UNII: BPD4DGQ314

Note

  • Humanized anti-CD20 monoclonal antibody; used in combination with the humanized anti-CD22 antibody, epratuzumab, for the therapy of non-Hodgkin's lymphoma.

Molecular Formula

  • C6458-H9918-N1706-O2026-S46
 

Classification Codes

  • Antineoplastic Agents
  • Treatment of Non-Hodgkin's Lymphoma
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • Veltuzumab
  • Veltuzumab [USAN:INN]

Synonyms

  • hA20
  • IMMU-106
  • Immunoglobulin G1, anti-(human B-lymphocyte antigen CD20 (Membrane-spanning 4-domains subfamily A member 1, Leu-16, Bp35)); (218- arginine,360-glutamic acid,362-methionine)humanized mouse monoclonal hA20 gamma1 heavy chain (224-213')-disulfide with humanized mouse monoclonal hA20 kappa light chain (230-230'':233-233'')-bisdisulfide dimer
  • Monoclonal antibody IMMU-106
  • UNII-BPD4DGQ314
  • Veltuzumab

Systematic Name

  • Immunoglobulin G1, anti-(human CD20 (antigen)) (human-mouse monoclonal hA20 heavy chain), disulfide with human-mouse monoclonal hA20 kappa-chain, dimer

Registry Numbers

CAS Registry Number

  • 728917-18-8

FDA UNII

  • BPD4DGQ314

System Generated Number

  • 0728917188